티스토리 뷰

Institute of Microbial Chemistry (BIKAKEN)

Bioactive Compounds

 

Bioactive compounds listed here are produced by the Institute of Microbial Chemistry (BIKAKEN). These products are useful for drug screenings and various pharmacological activity assays (inhibition assays).

What is BIKAKEN

The Institute of Microbial Chemistry (BIKAKEN) was established in 1962 using funds raised from royalties from the new antibiotic kanamycin, which was discovered by the late Dr. Hamao Umezawa. The institute has since given rise to numerous beneficial antibiotics, including kasugamycin, which is highly effective against rice blast, and bleomycin, which was the world’s first target-specific anticancer agent. It has continued to conduct research and development on antibacterial agents, anticancer agents, antiviral agents, etc. by microbial drug discovery, as well as organic synthesis research and process research on pharmaceutical products. To date, there have been 14 medicines created by the Institute of Microbial Chemistry, including the antibacterial agents dibekacin and arbekacin, the anticancer agents bleomycin, peplomycin, aclarubicin, the veterinary agents aivlosin, tildipirosin, and the pesticide kasugamycin. BIKAKEN’s unique bioactive compounds from microorganisms are widely used in the world as research reagents and contribute to scientific development.

Product Information

Enzyme Inhibitor or Enzyme Resistant Substance

Biological Activity

* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.

coresciences 코아사이언스 Funakoshi Korea distributor 후나코시 한국대리점